Serax and Agranulocytosis - a phase IV clinical study of FDA data

Summary:

Agranulocytosis is reported as a side effect among people who take Serax (oxazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dilaudid, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Agranulocytosis when taking Serax. It is created by eHealthMe based on reports of 1,473 people who have side effects when taking Serax from the FDA, and is updated regularly.

What is Serax?

Serax has active ingredients of oxazepam. It is often used in stress and anxiety. eHealthMe is studying from 1,542 Serax users. Check the latest studies of Serax.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,325 drugs and 3,597 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 28, 2026

1,473 people reported to have side effects when taking Serax.
Among them, 26 people (1.77%) have Agranulocytosis.

Among these 26 people:

How long have people been on Serax when they have Agranulocytosis? *

What is the gender of people who have Agranulocytosis when taking Serax? *

female: 70.83 %
male: 29.17 %

What is the age of people who have Agranulocytosis when taking Serax? *

What are other drugs people take besides Serax? *

What are other side effects people have besides Agranulocytosis? *

Fever: 9 people, 34.62%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 34.62%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 6 people, 23.08%
Pneumonia: 6 people, 23.08%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 23.08%
White Blood Cell Count Decreased: 6 people, 23.08%
Nausea (feeling of having an urge to vomit): 4 people, 15.38%
Nausea And Vomiting: 4 people, 15.38%
Diarrhea: 4 people, 15.38%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 3 people, 11.54%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 6 people, 23.08%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 15.38%
Pain: 4 people, 15.38%
Nausea (feeling of having an urge to vomit): 4 people, 15.38%
Osteoporosis (bones weak and more likely to break): 2 people, 7.69%
Indigestion: 2 people, 7.69%
Oedema (fluid collection in tissue): 1 person, 3.85%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.85%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 3.85%
Infection: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Serax and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serax:

Serax (1,542 reports)

Agranulocytosis treatments and more:

Agranulocytosis (213,267 reports)

Browse all side effects of Serax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,325 drugs)

Browse all the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,597 conditions)

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on oxazepam (the active ingredients of Serax) and Serax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.